Joseph Sinkule
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Joseph Sinkule was the founder of BANGI, Inc. (founded 2004), where the title held was President & Chief Executive Officer in 2012.
Dr. Sinkule is the founder of Anew Biotechnology, Inc. (founded 2014), holding the title Chairman & Chief Executive Officer since 2014.
Dr. Sinkule is the founder of Anew Oncology, Inc. (founded 2015), holding the title Chairman & Chief Executive Officer since 2015.
Dr. Sinkule was the founder of Virionics Corp.
(founded 2005), where the title held was Chief Executive Officer & Director from 2005 to 2008.
Dr. Sinkule is the founder of Greenland Mines Ltd. (founded 2004), holding the title Chairman & Chief Executive Officer since 2006.
Current job includes President, CEO, CFO & Director at ANEW Medical, Inc. since 2020.
Former job includes Chairman & Chief Scientific Officer at Apthera, Inc. from 2005 to 2009.
Education includes undergraduate degree from the University of Nebraska in 1976 and doctorate from the University of Nebraska Medical Center in 1980.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
5.23% | 30.04.2026 | 6’346’700 ( 5.23% ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Anew Biotechnology, Inc.
Anew Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Vorstandsvorsitzender | 01.01.2014 |
ANEW Medical Operating, Inc.
ANEW Medical Operating, Inc. Financial ConglomeratesFinance Operates as a development stage company | Vorstandsvorsitzender | 14.12.2020 |
Anew Oncology, Inc. | Vorstandsvorsitzender | 01.01.2015 |
| Unternehmen | Position | Ende |
|---|---|---|
Virionics Corp.
Virionics Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies and vaccines to treat diseases | Gründer | 01.01.2008 |
| BANGI INC. | Gründer | - |
Apthera, Inc.
Apthera, Inc. Medical/Nursing ServicesHealth Services Develops a pipeline of peptide-based immunotherapies for cancers | Vorsitzender | 11.10.2009 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
University of Nebraska
University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anew Oncology, Inc. | |
ANEW Medical Operating, Inc.
ANEW Medical Operating, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
University of Nebraska Medical Center
University of Nebraska Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BANGI, Inc.
BANGI, Inc. BiotechnologyHealth Technology Develops its licenses for patents pertaining to the technology utilized in the prevention and treatment of hepatitis C | Health Technology |
Apthera, Inc.
Apthera, Inc. Medical/Nursing ServicesHealth Services Develops a pipeline of peptide-based immunotherapies for cancers | Health Services |
Virionics Corp.
Virionics Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies and vaccines to treat diseases | Health Technology |
Anew Biotechnology, Inc.
Anew Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen